Inside Johnson & Johnson’s bankruptcy two-step
We’ll send you a myFT Daily Digest email rounding up the latest Behind the Money news every morning.
Johnson & Johnson, one of the world’s largest healthcare companies, is facing thousands of lawsuits from people alleging they got cancer from using one of their oldest products: talc-based baby powder.
To manage the growing liability, J&J recently deployed a controversial new bankruptcy manoeuvre known as the Texas Two-Step.
In this week’s episode, we explore whether J&J’s use of this manoeuvre is setting a new precedent for corporations to evade accountability in America.
Update: A new version of this episode was uploaded on June 21, 2022 to update the number and outcome of trials 3M has faced related to one of its products.
Clip courtesy of NBC News
For further reading:
Johnson & Johnson’s ‘Texas-two-step’ sparks outcry over US bankruptcy regime
Architects of ‘Texas two-step’ lambast J&J for its use of the manoeuvre
‘Texas two-step’ outcry risks ending fee bonanza for law firm Jones Day
J&J’s Texas two-step waltzes over its liabilities
On Twitter, follow Jamie Smyth (@JamieSmythF) and Michela Tindera (@mtindera07)
Read a transcript of this episode on FT.com
See acast.com/privacy for privacy and opt-out information.